Literature DB >> 9139801

Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1.

A Ramalingam1, A Hirai, E A Thompson.   

Abstract

Glucocorticoids inhibit the proliferation of fibroblastic cells in vivo and in culture; however, the molecular mechanism that accounts for this effect has remained obscure. We have undertaken to elucidate the mechanism whereby glucocorticoids decrease the rate of proliferation of mouse L929 fibroblastic cells. Addition of dexamethasone to mid-log phase fibroblasts prolongs G1 phase. This increase in the G1 interval is associated with, and probably due to, inhibition of phosphorylation of the product of the Rb-1 tumor suppressor gene, pRb. Inhibition of pRb phosphorylation by cyclin D-dependent kinases can be demonstrated in vitro. Nevertheless, there is no detectable change in the expression of cyclin D1, cyclin D2, or cyclin D3. Cyclin-dependent kinase-4 (Cdk4) and Cdk6 are not down-regulated in L929 cells after addition of glucocorticoids, and the abundance of cyclin D/Cdk4 complexes does not change. Inhibition of pRb kinase activity is associated with an increase in the abundance of one of the Cdk inhibitors, p21Cip1. The abundance of another cyclin kinase inhibitor, p27Kip1, remains constant. The amount of Cdk4 that is bound to p21Cip1 increases rapidly after addition of dexamethasone, and the activity of Cdk4-pRb kinase decreases in parallel. These results indicate that glucocorticoid inhibition of fibroblast proliferation is due to induction of p21Cip1, which binds to and inactivates cyclinD/Cdk4 complexes. The abundance of p21 mRNA increases about 5-fold within 2 h after addition of dexamethasone. This effect does not obtain in L929 mutants that are null for the glucocorticoid receptor, and a variant that expresses the glucocorticoid receptor from a tetracycline-repressible expression vector demonstrates induction of p21 mRNA only in the absence of tetracycline. Cycloheximide does not block induction of p21 mRNA, and dexamethasone has no detectable effect on the apparent rate of degradation of p21 mRNA. Nuclear run-on transcription of the Cip1 gene increases within 2 h after addition of dexamethasone. This effect can be blocked by tetracycline-mediated repression of the glucocorticoid receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139801     DOI: 10.1210/mend.11.5.9923

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

1.  Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids.

Authors:  O J Shah; S R Kimball; L S Jefferson
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

2.  Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.

Authors:  C Caelles; J M González-Sancho; A Muñoz
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

3.  cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis.

Authors:  Alysia Kern Lovgren; Martina Kovarova; Beverly H Koller
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

4.  Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids.

Authors:  I Rogatsky; A B Hittelman; D Pearce; M J Garabedian
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer.

Authors:  Stamatios Theocharis; Gregorios Kouraklis; Alexandra Margeli; Emmanuel Agapitos; Sotirios Ninos; Gabriel Karatzas; Antonios Koutselinis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.

Authors:  Sophie Turban; Xiaoxia Liu; Lynne Ramage; Scott P Webster; Brian R Walker; Donald R Dunbar; John J Mullins; Jonathan R Seckl; Nicholas M Morton
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

7.  Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring.

Authors:  Rudolph Reimer; Heike Helmbold; Beata Szalay; Christian Hagel; Heinrich Hohenberg; Wolfgang Deppert; Wolfgang Bohn
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

8.  miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.

Authors:  Shlomit Kfir-Erenfeld; Noa Haggiag; Moshe Biton; Polina Stepensky; Nathalie Assayag-Asherie; Eitan Yefenof
Journal:  Oncotarget       Date:  2017-01-03

9.  ROS and ERK1/2-mediated caspase-9 activation increases XAF1 expression in dexamethasone-induced apoptosis of EBV-transformed B cells.

Authors:  Ga Bin Park; Yunock Choi; Yeong Seok Kim; Hyun-Kyung Lee; Daejin Kim; Dae Young Hur
Journal:  Int J Oncol       Date:  2013-05-20       Impact factor: 5.650

10.  Suppression of Fibrotic Reactions of Chitosan-Alginate Microcapsules Containing Porcine Islets by Dexamethasone Surface Coating.

Authors:  Min Jung Kim; Heon-Seok Park; Ji-Won Kim; Eun-Young Lee; Marie Rhee; Young-Hye You; Gilson Khang; Chung-Gyu Park; Kun-Ho Yoon
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.